Loss of RNase J leads to multi-drug tolerance and accumulation of highly structured mRNA fragments in Mycobacterium tuberculosis.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
07 2022
Historique:
received: 14 02 2022
accepted: 27 06 2022
revised: 25 07 2022
pubmed: 14 7 2022
medline: 28 7 2022
entrez: 13 7 2022
Statut: epublish

Résumé

Despite the existence of well-characterized, canonical mutations that confer high-level drug resistance to Mycobacterium tuberculosis (Mtb), there is evidence that drug resistance mechanisms are more complex than simple acquisition of such mutations. Recent studies have shown that Mtb can acquire non-canonical resistance-associated mutations that confer survival advantages in the presence of certain drugs, likely acting as stepping-stones for acquisition of high-level resistance. Rv2752c/rnj, encoding RNase J, is disproportionately mutated in drug-resistant clinical Mtb isolates. Here we show that deletion of rnj confers increased tolerance to lethal concentrations of several drugs. RNAseq revealed that RNase J affects expression of a subset of genes enriched for PE/PPE genes and stable RNAs and is key for proper 23S rRNA maturation. Gene expression differences implicated two sRNAs and ppe50-ppe51 as important contributors to the drug tolerance phenotype. In addition, we found that in the absence of RNase J, many short RNA fragments accumulate because they are degraded at slower rates. We show that the accumulated transcript fragments are targets of RNase J and are characterized by strong secondary structure and high G+C content, indicating that RNase J has a rate-limiting role in degradation of highly structured RNAs. Taken together, our results demonstrate that RNase J indirectly affects drug tolerance, as well as reveal the endogenous roles of RNase J in mycobacterial RNA metabolism.

Identifiants

pubmed: 35830479
doi: 10.1371/journal.ppat.1010705
pii: PPATHOGENS-D-22-00292
pmc: PMC9312406
doi:

Substances chimiques

RNA, Messenger 0
Endoribonucleases EC 3.1.-
Ribonucleases EC 3.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1010705

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI143575
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI107774
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nucleic Acids Res. 2022 Apr 12;:
pubmed: 35412617
Nat Commun. 2020 Oct 23;11(1):5374
pubmed: 33097713
Microorganisms. 2021 Feb 14;9(2):
pubmed: 33672886
mBio. 2017 Feb 7;8(1):
pubmed: 28174313
Methods Mol Biol. 2015;1285:177-99
pubmed: 25779316
Microb Biotechnol. 2017 Nov;10(6):1616-1627
pubmed: 28730700
Curr Opin Pulm Med. 2018 May;24(3):244-252
pubmed: 29470252
mBio. 2019 Jul 2;10(4):
pubmed: 31266866
Proc Natl Acad Sci U S A. 2019 Sep 24;116(39):19665-19674
pubmed: 31488707
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Mol Microbiol. 2003 Apr;48(1):77-84
pubmed: 12657046
PLoS Pathog. 2011 Nov;7(11):e1002342
pubmed: 22072964
Nucleic Acids Res. 2015 Jun 23;43(11):5550-9
pubmed: 25940620
mBio. 2019 Jul 30;10(4):
pubmed: 31363023
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Nucleic Acids Res. 2013 Jan 7;41(1):288-301
pubmed: 23093592
PLoS Pathog. 2020 Nov 30;16(11):e1009063
pubmed: 33253310
PLoS One. 2016 May 13;11(5):e0155127
pubmed: 27176494
PLoS Genet. 2014 Feb 27;10(2):e1004207
pubmed: 24586213
Nucleic Acids Res. 2019 Jun 20;47(11):5892-5905
pubmed: 30957850
Science. 2004 Sep 10;305(5690):1622-5
pubmed: 15308767
Nucleic Acids Res. 2005 Apr 14;33(7):2141-52
pubmed: 15831787
J Biol Chem. 2004 Sep 17;279(38):40174-84
pubmed: 15247240
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W70-4
pubmed: 18424795
Nat Genet. 2013 Oct;45(10):1255-60
pubmed: 23995137
Genome Biol. 2014;15(12):550
pubmed: 25516281
Structure. 2011 Sep 7;19(9):1252-61
pubmed: 21893286
Science. 2016 Dec 16;354(6318):
pubmed: 27980159
Nucleic Acids Res. 2015 Sep 18;43(16):8066-76
pubmed: 26253740
J Mol Biol. 1994 Jan 28;235(4):1239-50
pubmed: 8308887
Mol Microbiol. 2011 Dec;82(5):1260-76
pubmed: 22014150
Nat Commun. 2016 Apr 25;7:11392
pubmed: 27109928
Evol Bioinform Online. 2020 Jul 27;16:1176934320944932
pubmed: 32782426
RNA Biol. 2020 Oct;17(10):1480-1491
pubmed: 32552320
mBio. 2011 Jun 14;2(3):e00100-11
pubmed: 21673191
Front Cell Infect Microbiol. 2019 Jan 09;8:449
pubmed: 30687646
J Bacteriol. 2006 Dec;188(24):8460-8
pubmed: 17028284
PLoS Genet. 2012;8(3):e1002520
pubmed: 22412379
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28893793
Vaccine. 2006 Sep 11;24(37-39):6309-20
pubmed: 16860907
Mol Microbiol. 2006 Jun;60(5):1109-22
pubmed: 16689789
PLoS Pathog. 2018 Dec 7;14(12):e1007453
pubmed: 30532201
Nucleic Acids Res. 2013 Jan 7;41(1):509-17
pubmed: 23125364
Microorganisms. 2021 Mar 25;9(4):
pubmed: 33805851
PLoS Pathog. 2011 Sep;7(9):e1002251
pubmed: 21980284
Cells. 2020 Mar 03;9(3):
pubmed: 32138343
Nat Struct Mol Biol. 2015 Apr;22(4):342-344
pubmed: 25775268
Crit Rev Biochem Mol Biol. 2014 Mar-Apr;49(2):91-101
pubmed: 24328927
mSystems. 2020 Aug 4;5(4):
pubmed: 32753506
RNA Biol. 2014;11(7):855-64
pubmed: 24922065
mBio. 2014 May 20;5(3):e01125-14
pubmed: 24846381
Nucleic Acids Res. 2014 Oct;42(18):11763-76
pubmed: 25217589
Tuberculosis (Edinb). 2014 Mar;94(2):170-7
pubmed: 24440549
Nucleic Acids Res. 2021 Jul 2;49(W1):W431-W437
pubmed: 33956157
mBio. 2017 Jan 17;8(1):
pubmed: 28096490
Nature. 2014 Sep 18;513(7518):418-21
pubmed: 25043002
Nucleic Acids Res. 2005 Feb 01;33(2):e21
pubmed: 15687379
Nat Microbiol. 2018 Sep;3(9):1032-1042
pubmed: 30082724
Mol Microbiol. 2003 Feb;47(4):1075-89
pubmed: 12581360
Clin Microbiol Rev. 2020 Oct 14;34(1):
pubmed: 33055230
Am J Respir Crit Care Med. 2018 Nov 1;198(9):1208-1219
pubmed: 29877726
mBio. 2019 Apr 23;10(2):
pubmed: 31015328
Front Microbiol. 2021 Feb 15;12:639660
pubmed: 33658988
Front Microbiol. 2019 Mar 26;10:591
pubmed: 30984135
Gene. 2012 May 25;500(1):85-92
pubmed: 22446041
Nat Commun. 2019 May 13;10(1):2128
pubmed: 31086182
Mol Microbiol. 2003 May;48(3):833-43
pubmed: 12694625
Methods Mol Biol. 2009;465:173-86
pubmed: 20560078
Nat Struct Mol Biol. 2008 Feb;15(2):206-12
pubmed: 18204464
Methods Mol Biol. 2021;2314:513-531
pubmed: 34235668
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
J Bacteriol. 2004 Aug;186(15):5017-30
pubmed: 15262939
Nat Commun. 2014 Jun 30;5:4306
pubmed: 24978671
RNA Biol. 2016;13(2):243-53
pubmed: 26726773
J Bacteriol. 2020 Apr 9;202(9):
pubmed: 32094162
Microbiology (Reading). 2010 Jan;156(Pt 1):81-87
pubmed: 19797356
Proc Natl Acad Sci U S A. 2021 Aug 31;118(35):
pubmed: 34426499
Front Microbiol. 2020 Jun 03;11:1055
pubmed: 32582060
Nat Commun. 2018 Oct 11;9(1):4218
pubmed: 30310059

Auteurs

Maria Carla Martini (MC)

Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, Massachusetts, United States of America.

Nathan D Hicks (ND)

Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Junpei Xiao (J)

Program in Bioinformatics and Computational Biology, Worcester Polytechnic Institute, Worcester, Massachusetts, United States of America.

Maria Natalia Alonso (MN)

Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, Massachusetts, United States of America.

Thibault Barbier (T)

Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Jaimie Sixsmith (J)

Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Sarah M Fortune (SM)

Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Scarlet S Shell (SS)

Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, Massachusetts, United States of America.
Program in Bioinformatics and Computational Biology, Worcester Polytechnic Institute, Worcester, Massachusetts, United States of America.

Articles similaires

Humans Endoribonucleases RNA, Messenger RNA Caps Gene Expression Regulation
Arabidopsis Arabidopsis Proteins Osmotic Pressure Cytoplasm RNA, Messenger
Animals Active Transport, Cell Nucleus RNA, Messenger Humans SARS-CoV-2
Deep Learning RNA, Bacterial RNA, Small Untranslated Mycobacterium tuberculosis Computational Biology

Classifications MeSH